The effects of recombinant human thyrotropin, in normal subjects and patients with goitre

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Endocrinology

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2265.2004.02134.xPMID 15579178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant Human Thyroid-Stimulating Hormone

  2012cited by this paper
• Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial.

  2004influential reference
• Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres

  2004influential reference
• Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.

  2004influential reference
• Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

  2003influential reference
• Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters.

  2003cited by this paper
• Management of simple nodular goiter: current status and future perspectives.

  2003influential reference
• Near-Lethal Respiratory Failure After Recombinant Human Thyroid-Stimulating Hormone Use in a Patient with Metastatic Thyroid Carcinoma

  2003cited by this paper
• Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

  2003cited by this paper
• The genetics of autoimmune endocrine disease

  2003cited by this paper
• Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres.

  2002cited by this paper
• The use of recombinant human TSH in the follow‐up of differentiated thyroid cancer: experience from a large patient cohort in a single centre

  2002cited by this paper
• Management of the nontoxic multinodular goiter: a North American survey.

  2002cited by this paper
• Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration.

  2001cited by this paper
• Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.

  2001cited by this paper
• Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects.

  2001cited by this paper
• The effect of recombinant human tsh on the thyroid (123)i uptake in iodide treated normal subjects.

  2001cited by this paper
• Management of the nontoxic multinodular goitre: A European questionnaire study

  2000cited by this paper
• Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism.

  2000cited by this paper
• Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature.

  2000cited by this paper
• Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.

  2000cited by this paper
• Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain.

  1999influential reference
• Comparison of pituitary and recombinant human thyroid-stimulating hormone (rhTSH) in a multicenter collaborative study: establishment of the first World Health Organization reference reagent for rhTSH.

  1999cited by this paper
• Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome.

  1999cited by this paper
• The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function.

  1999cited by this paper
• A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

  1999cited by this paper
• Determinants of longterm outcome of radioiodine therapy of sporadic non‐toxic goitre

  1999cited by this paper
• An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.

  1998cited by this paper
• Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.

  1997cited by this paper
• Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

  1997cited by this paper
• Serum TSH and the response to radioiodine treatment of toxic multinodular goitre.

  1997cited by this paper
• Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects.

  1997cited by this paper
• Acute changes in thyroid volume and function following 131I therapy of multinodular goitre

  1994influential reference
• Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).

  1994cited by this paper
• Recombinant Human Thyroid Stimulating Hormone: Development of a Biotechnology Product for Detection of Metastatic Lesions of Thyroid Carcinoma

  1993cited by this paper
• Radioiodine treatment of multinodular non-toxic goitre.

  1993cited by this paper
• Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity.

  1993cited by this paper
• Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey.

  1992cited by this paper
• Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells.

  1991cited by this paper
• An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone.

  1991cited by this paper
• Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells.

  1991cited by this paper
• Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.

  1988cited by this paper
• Isolation and characterization of the human thyrotropin beta-subunit gene. Differences in gene structure and promoter function from murine species.

  1988cited by this paper
• Molecular cloning of the human thyrotropin‐β subunit gene

  1985cited by this paper
• Molecular cloning of the human thyrotropin-beta subunit gene.

  1985cited by this paper
• Glycoprotein hormones: structure and function.

  1981cited by this paper
• Neutralizing antibodies to bovine thyrotropin in immunized patients with thyroid cancer.

  1980cited by this paper
• Human reaction to bovine TSH: concise communication.

  1978cited by this paper
• Unusual Thyroid Responses to Thyrotropin Stimulation1

  1968cited by this paper
• Unusual thyroid responses to thyrotropin stimulation.

  1968cited by this paper
• Suppression of human thyroid function by antibodies to bovine thyrotropin.

  1967cited by this paper
• THYROID RESPONSE TO HUMAN THYROTROPIN IN MAN.

  1965cited by this paper
• Thyroid Response to Human Thyrotropin in Man1

  1965cited by this paper
• Thyroiditis following administration of thyroid-stimulating hormone.

  1960cited by this paper
• Treatment of thyroid cancer metastases with TSH and I131 during thyroid hormone medication.

  1953cited by this paper
• Regulation by Thyroid-stimulating Hormone of Sodium/ Iodide Symporter Gene Expression and Protein Levels in Frtl-5 Cells

  year unknowncited by this paper

• Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase

  2023cites this paper
• Determining the frequency of thyroid parameter measurements following rhTSH administration in a healthy, older population

  2021cites this paper
• Familial Longevity is Associated with an Attenuated Thyroidal Response to Recombinant Human Thyroid Stimulating Hormone

  2020cites this paper
• [Challenges in the management of amiodarone-induced thyrotoxicosis].

  2018cites this paper
• THYROIDMANAGER . ORG CHAPTER 17 – MULTINODULAR GOITER

  2016cites this paper
• The role of radioiodine therapy in benign nodular goitre.

  2014cites this paper
• Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.

  2012cites this paper
• Biological Activity of Thyrotropin in Two Teleost Fish, Red Drum (Sciaenops ocellatus) and Goldfish (Carassius auratus)

  2011influential citation
• Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy

  2011cites this paper
• AACE / AME / ETA Guidelines AMERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS , ASSOCIAzIONE MEDICI ENDOCRINOlOgI , AND EuROPEAN ThyROID ASSOCIATION MEDICAl guIDElINES fOR ClINICAl PRACTICE fOR ThE DIAgNOSIS AND MANAgEMENT Of ThyROID NODulES

  2010cites this paper
• Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone‐induced thyrotoxicosis: a cautionary note

  2010cites this paper
• Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.

  2010cites this paper
• American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules.

  2010cites this paper
• Dose‐dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0·1, 0·3 and 0·9 mg of rhTSH

  2010cites this paper
• AACE / AME / ETA Guidelines AMERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS , ASSOCIAzIONE MEDICI ENDOCRINOlOgI , AND EuROPEAN ThyROID ASSOCIATION MEDICAl guIDElINES fOR ClINICAl PRACTICE fOR ThE DIAgNOSIS AND MANAgEMENT Of ThyROID NODulES

  2010cites this paper
• Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.

  2009influential citation
• Radioiodine treatment for non-toxic goitre

  2009cites this paper
• Administração prévia do TSH humano recombinante, em diferentes doses, no tratamento do bócio multinodular com iodo radioativo: um estudo randomizado, duplo cego, controlado com placebo

  2009cites this paper
• Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre

  2009cites this paper
• Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration.

  2008cites this paper
• An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter

  2008cites this paper
• Problems associated with the use of thyrogen in patients with a thyroid gland.

  2008cites this paper
• Evaluation and treatment of thyroid nodules: a clinical guide.

  2008cites this paper
• Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin

  2007cites this paper
• Transient Goiter Enlargement after Administration of 0.3 mg of Recombinant Human Thyrotropin in Patients with Benign Nontoxic Nodular Goiter: A Randomized, Double-Blind, Crossover TrialNielsen VE, Bonnema SJ, Hegedüs L (Odense Univ, Denmark) J Clin Endocrinol Metab 91:1317–1322, 2006§

  2007cites this paper
• Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.

  2007cites this paper
• Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone.

  2007cites this paper
• Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH)

  2006cites this paper
• 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.

  2006cites this paper
• Estimation of Serum TSH Receptor Autoantibody Concentration and Affinity

  2006cites this paper
• Prolonged follow‐up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH

  2006cites this paper
• Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.

  2006cites this paper
• Index

  2004cites this paper
• Near-Lethal Respiratory Failure After Recombinant Human Thyroid-Stimulating Hormone Use in a Patient with Metastatic Thyroid Carcinoma

  2003cites this paper